The research behind what we prescribe. Clinical evidence, trial data and the reasoning our physicians use when they build a protocol — written up plainly, and kept current as the literature moves.
Early research examines whether GLP-1 medications may be linked to a reduced risk of an Alzheimer's diagnosis. These findings are preliminary and under ongoing study.
Read more Semaglutide and Alzheimer’s ResearchSome studies observe reduced alcohol cravings in people taking GLP-1 medications. Researchers are investigating the mechanisms behind this effect.
Read more GLP-1 Medications and Alcohol UseTestosterone plays an important role in women’s health too. Research continues into how carefully monitored, physician-guided therapy may support it. Learn more
Read more Women’s Health and TestosteroneTestosterone levels change naturally with age. Understanding these changes helps physicians decide whether hormone therapy is appropriate and monitor it safely.
Read more Understanding Testosterone Over TimeBeyond weight and blood sugar, ongoing research explores how GLP-1 therapies may support cardiovascular and metabolic health over time.
Read more GLP-1 and Long-Term WellnessSemaglutide targets the GLP-1 receptor; tirzepatide acts on both GLP-1 and GIP. Research suggests tirzepatide's dual action may yield greater average weight reduction…
Read more Semaglutide vs. TirzepatideSemaglutide is a once-weekly GLP-1 receptor agonist studied for blood-sugar management and weight reduction, helping regulate appetite with meaningful, sustained results…
Read more Once-Weekly SemaglutideGLP-1 is a hormone released in the gut after eating. Its discovery reshaped metabolic science and led to a new class of medications for blood-sugar control and weight…
Read more The Discovery of GLP-1